We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AdComms: Modify Opioid REMS for Targeted Approach
Two FDA advisory committees voted unanimously to recommend modifications to the REMS for extended-release and long-acting opioids, although the recommendation did not get into specific courses of action.